McKinley Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

McKinley Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,058	Closed	-$1.35M	–	494
2016 Q3	$1.35M	Buy	25,058 +14,543	+138%	+$934K	0.05%	228
2016 Q2	$773K	Buy	10,515 +2,715	+35%	+$192K	0.04%	233
2016 Q1	$498K	Sell	7,800 -159	-2%	-$10K	0.02%	245
2015 Q4	$548K	Buy	7,959 +125	+2%	+$8.26K	0.03%	245
2015 Q3	$464K	Sell	7,834 -677	-8%	-$42.9K	0.02%	253
2015 Q2	$566K	Sell	8,511 -624	-7%	-$41.1K	0.02%	252
2015 Q1	$589K	Sell	9,135 -12	-0.1%	-$751	0.02%	247
2014 Q4	$540K	Sell	9,147 -176	-2%	-$9.93K	0.02%	246
2014 Q3	$477K	Sell	9,323 -71	-0.8%	-$3.55K	0.02%	252
2014 Q2	$456K	Sell	9,394 -3,005	-24%	-$148K	0.02%	242
2014 Q1	$644K	Sell	12,399 -1,568	-11%	-$83.4K	0.03%	251
2013 Q4	$742K	Buy	13,967 +997	+8%	+$50.8K	0.03%	269
2013 Q3	$600K	Sell	12,970 -117	-0.9%	-$5.14K	0.03%	262
2013 Q2	$585K	Buy	+13,087	New	+$568K	0.03%	237

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

McKinley Capital Management's BMY Position: Q4 2016 in Review

McKinley Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 25,058 shares — an estimated $1.35M sold.

McKinley Capital Management first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $1.35M in Q3 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

McKinley Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
McKinley Capital Management sold 25,058 Bristol-Myers Squibb shares in Q4 2016, an estimated $1.35M.
McKinley Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
McKinley Capital Management's Bristol-Myers Squibb position peaked at $1.35M in Q3 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on McKinley Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.